Australian Institute of Health and Welfare (2021) Cancer data in Australia, AIHW, Australian Government, accessed 25 June 2022.
Australian Institute of Health and Welfare. (2021). Cancer data in Australia. Retrieved from https://www.aihw.gov.au/reports/cancer/cancer-data-in-australia
Cancer data in Australia. Australian Institute of Health and Welfare, 08 June 2021, https://www.aihw.gov.au/reports/cancer/cancer-data-in-australia
Australian Institute of Health and Welfare. Cancer data in Australia [Internet]. Canberra: Australian Institute of Health and Welfare, 2021 [cited 2022 Jun. 25]. Available from: https://www.aihw.gov.au/reports/cancer/cancer-data-in-australia
Australian Institute of Health and Welfare (AIHW) 2021, Cancer data in Australia, viewed 25 June 2022, https://www.aihw.gov.au/reports/cancer/cancer-data-in-australia
Get citations as an Endnote file:
PDF | 3.3Mb
For around 70 cancers, this data visualisation provides a wide range of cancer-related statistics that, together, present a summary of national cancer data and trends over time. Help with terms, and information about the data, is available by placing the mouse pointer over the icons found near the top of the page. Please note that data on median and mean age at diagnosis and at death that was previously presented in this visualisation are now available in the ‘cancer incidence by age’ and ‘cancer mortality by age’ data visualisations respectively.
Cancer data in Australia - a summary of incidence, mortality, survival and prevalence of cancer in Australia.
This visualisation contains trend information for around 60 cancers divided across Figures 1 to 4 and Table 1.
Figure 1 is a line graph that contains information on the number of cancer cases or deaths and age-standardised rates of cancer diagnosis or cancer death between 1982 and 2020.
Figure 2 is a line graph that contains information on the crude rate of cancer diagnosis or cancer death for various 5-year age groups from 0–4, 5–9, etc. up to 90+ for a selected year between 1982 and 2020.
Table 1 contains cancer-related summary statistics such as the number of cases or deaths, crude and age-standardised rate of diagnosis or death and mean and median ages at diagnosis or death.
Figure 3 is a line graph that contains information on 5-year relative survival rates for cancer from 1987–1991 to 2012–2016 for a selected cancer.
Figure 4 is a column graph that contains information on cancer prevalence, or, the number of people alive at 31 December 2015 who have been diagnosed with the selected cancer in the last year, last 5 years and 34 years.
Please note that cancer incidence statistics from 2018 to 2021, and cancer mortality data in 2020 and 2021, are projections; all other statistics are derived from actual data.
Data informing the summary dashboard is available as supplementary tables.
ABS (Australian Bureau of Statistics) 2018. Population projections, Australia, 2017 (base) – 2066. ABS cat. no. 3222.0. Canberra: ABS.
AIHW (Australian Institute of Health and Welfare) 2019. BreastScreen Australia monitoring report 2018. Cancer series no.127. Cat no. CAN128. Canberra: AIHW
Al-Marhoon M, Osman A, Kamal M and Shokier A 2011. Incidental vs symptomatic renal tumours: Survival outcomes. Arab Journal of Urology 9(1): 17–21.
Brenner H and Gefeller O 1996. An alternative approach to monitoring cancer patient survival. Cancer78:2004–10.
Dickman PW 2004. Estimating and modelling relative survival using SAS. Stockholm: Karolinska Institutet. Viewed 26 May 2020.
Ederer F & Heise H 1959. Instructions to IBM 650 programmers in processing survival computations. Methodological note.
Greenwood M 1926. The errors of sampling of the survivorship table. Reports on public health and medical subjects. Vol 33. London: Her Majesty’s Stationery Office.
Jensen O, Parkin D, MacLennan R, Muir C & Skeet R (eds) 1991. Cancer registration: principles and methods. IARC scientific publications no. 95. Lyon: IARC.
Luke C, Tracey E, Stapleton A and Roder D 2010. Exploring contrary trends in bladder cancer incidence, mortality and survival: implications for cancer research and cancer control. Internal Medicine Journal 40:357–62.
Qaseem A, Usman N, Jayaraj J S, et al. (September 02, 2019) Cancer of Unknown Primary: A Review on Clinical Guidelines in the Development and Targeted Management of Patients with the Unknown Primary Site. Cureus 11(9): e5552. doi:10.7759/cureus.5552
Skuladottir H & Olsen JH 2003. Conditional survival of patients with the four major histologic subgroups of lung cancer in Denmark. Journal of Clinical Oncology 21(16):3035–40.
Smith D Supramaniam R, Marshall V and Armstrong B 2008. Prostate cancer and prostate specific antigen testing in New South Wales. Medical Journal of Australia 189(6): 315–18.
Vaccarella S, Franceschi S, Bray F, Wild C, Plummer M and Dal Maso L 2016. The increase in thyroid cancer may be due to an increase in medical surveillance and the introduction of new diagnostic techniques, such as neck ultrasonography. The New England Journal of Medicine 375: 614–17.
We'd love to know any feedback that you have about the AIHW website, its contents or reports.
The browser you are using to browse this website is outdated and some features may not display properly or be accessible to you. Please use a more recent browser for the best user experience.